Protalix BioTherapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2023.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $155K.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$365K, a 84.8% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.89M, a 36.9% decline from 2022.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.38M, a 80.6% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.12M, a 22.9% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.89M -$511K -36.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$1.38M +$5.74M +80.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$7.12M +$2.11M +22.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$9.23M -$1.67M -22.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$7.56M -$410K -5.74% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 -$7.15M +$41.8M +85.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$48.9M -$52.9M -1327% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $3.99M +$7.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$3.61M +$1.13M +23.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 -$4.74M -$4.07M -603% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$674K -$1.23M -222% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 $554K +$552K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $2K* Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.